At present, the Company has a modern standard laboratory of nearly 4,000 square meters, has a complete R&D and pilot test platform, and has established technical platforms such as Prokaryotic Cell Fermentation, Eukaryotic Cell Fermentation, CHO Cell Fermentation, Protein Purification, Crystallization and Drying, laying the foundation for the development of Protein and Peptide Drugs; Using the Gene Editing, Stem Cell Culture Differentiation and other technologies, an efficient and controllable Stem Cell Differentiation Platform has been established, and Pluripotent Stem Cells are directed into the various Functional Cells for the Research and Development of Cell Therapy and other related drugs. In terms of R&D equipment, the company has provided the complete and sophisticated R&D equipment for the R&D platform, including the Liquid Mass Chromatography System, Flow Cytometer, Microbial Fermenter, Capillary Electrophoresis Instrument, Particle Size and Potential Analyzer, Preparation and Purification instrument, AKTA AVANT Protein Purification System and other R&D equipment of about 50 million CNY.

The company will rely on its own innovative technology platform to promote the R&D and marketing of innovative drugs, so that the innovative results can better serve patient needs and cure diseases.